FDA Adverse Event Injury Summary report: N

LENSAR LASER SYSTEM-FS 3D

MDR report key: 5402072 · Received February 1, 2016

Report

Report Number
3009026057-2016-00001
Event Type
Injury
Date Received
February 1, 2016
Date of Event
January 4, 2016
Report Date
February 3, 2016
Manufacturer
LENSAR, LLC
Product Code
OOE
PMA / PMN Number
K120214
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OR, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

REVIEW OF THE TREATMENT FILES WAS PERFORMED AND NOTED THAT THE SUCTION RING WAS MILDLY DECENTERED. THE INITIAL SUCTION QUALITY WAS SUB-PAR BASED UPON NO SPECKLE PATTERN OVER 50% OF THE SUCTION RING. FROM ONSET IT WAS NOTICED A MILD FLUID LOSS OCCURRING DURING TREATMENT, THERE WERE SMALL OCULAR MOVEMENTS THROUGHOUT THE PROCEDURE AND ON SLIDE 28-31 YOU SEE A MARKED INCREASE IN EYE MOVEMENT FOLLOWED BY A FULL BREAK IN SUCTION ON FRAME 32. FRAME 33 SHOWS FRAGMENTATION PATTERN DELIVERED INTO THE CORNEA. NO ADDITIONAL SURGICAL INTERVENTION WAS REPORTED INITIALLY BY THE DOCTOR. PES CAS CONTACTED THE OFFICE IN SEVERAL OCCASIONS REQUESTING THE PATIENT-POST OPERATIVE CLINICAL RESULTS, BUT THE DOCTOR'S OFFICE DID NOT PROVIDE THE REQUESTED INFORMATION. ROOT CAUSE: PATIENT MOVED.

Additional Manufacturer Narrative · 1

INVESTIGATION INCLUDING ROOT CAUSE ANALYSIS IS IN PROGRESS. A SUPPLEMENTAL MDR WILL BE FILED AS NECESSARY IN ACCORDANCE WITH 21 CFR 803. 56 WHEN ADDITIONAL REPORTABLE INFORMATION BECOMES AVAILABLE.

Description of Event or Problem · 1

DOCTOR REPORTED THAT A SUCTION LOSS OCCURRED AT 66% AND ABORTED. DURING PHACO THE SURGEON NOTICED THAT THE CORNEA HAD BEEN MARKED.

Description of Event or Problem · 1

DOCTOR REPORTED THAT A SUCTION LOSS OCCURRED AT 66% AND ABORTED. DURING PHACO THE SURGEON NOTICED THAT THE CORNEA HAD BEEN MARKED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
59624 LENSAR LASER SYSTEM-FS 3D LENSAR LASER SYSTEM-FS 3D OOE LENSAR, LLC 70-00005-001 N/A

Patients

Seq Age Sex Outcome Treatment
1 Other